Last reviewed · How we verify

Qiliqiangxin Capsule

Harbin Medical University · FDA-approved active Small molecule

Qiliqiangxin is a traditional Chinese medicine capsule that improves cardiac function and reduces heart failure symptoms through multi-target anti-inflammatory and cardioprotective effects.

Qiliqiangxin is a traditional Chinese medicine capsule that improves cardiac function and reduces heart failure symptoms through multi-target anti-inflammatory and cardioprotective effects. Used for Chronic heart failure, Congestive heart failure with reduced ejection fraction.

At a glance

Generic nameQiliqiangxin Capsule
SponsorHarbin Medical University
Drug classTraditional Chinese medicine herbal preparation
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Qiliqiangxin contains a blend of traditional Chinese herbs formulated to enhance myocardial contractility, reduce cardiac remodeling, and suppress inflammatory pathways implicated in heart failure progression. The preparation works through multiple mechanisms including inhibition of TNF-α and other pro-inflammatory cytokines, improvement of cardiac energy metabolism, and reduction of myocardial fibrosis.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: